The Chemours Co (FRA:2CU)
€ 14.76 +0.53 (+3.72%) Market Cap: 2.17 Bil Enterprise Value: 5.49 Bil PE Ratio: 0 PB Ratio: 11.62 GF Score: 67/100

Q4 2024 Chemours Co Earnings Call Transcript

Feb 18, 2025 / 01:00PM GMT
Release Date Price: €15.97 (+0.44%)

Key Points

Positve
  • The Chemours Co (CC) exceeded its adjusted EBITDA expectations for the fourth quarter, demonstrating strong operational performance.
  • The TSS business achieved a quarterly sales record, driven by 23% year-over-year growth in Opteon refrigerants.
  • The company completed an expansion at its Corpus Christi site to support increased demand for Opteon refrigerants.
  • The TT Transformation Plan yielded approximately $140 million in annual savings, exceeding the initial target of $125 million.
  • The Chemours Co (CC) fully remediated its four material weaknesses in internal control, marking significant progress in strengthening its long-term strategic pillar.
Negative
  • Consolidated net sales for the fourth quarter were down 1% compared to the prior year, driven by a 3% decline in pricing.
  • The company reported a net loss of $8 million for the fourth quarter, compared to a net loss of $18 million in the prior year.
  • Full-year consolidated net sales decreased by 5% compared to the prior year, impacted by pricing decreases and portfolio changes.
  • Adjusted EBITDA for the full year decreased to $786 million from $1 billion in the prior year, due to pricing decreases and higher costs.
  • The APM segment experienced a 9% decline in net sales for the full year, driven by weaker demand in economically sensitive end markets.
Operator

Good morning, my name is Michelle and I will be your conference operator today. I would like to welcome everyone to the Chemours Company fourth quarter 2024 research results conference call. (Operator Instructions) I would like to remind everyone that this conference call is being recorded.

I would now like to hand the conference call over to Brandon Ontjes, Vice President of Investor Relations for Chemours. You may begin your conference.

Brandon Ontjes
Chemours Co - Vice President - Investor Relations

Good morning, everybody. Welcome to the Chemours Company's Fourth Quarter and Full Year 2024 Earnings Conference Call. I'm joined today by Denise Dignam, Chemours' President and Chief Executive Officer; and our Senior Vice President and Chief Financial Officer, Shane Hostetter.

Before we start, I would like to remind you that comments made on this call as well as in the supplemental information provided on our website contain forward-looking statements that involve risks and uncertainties as described in or SEC filing. These forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot